ÃÖÁ¾ÆíÁýÀÏ10.02 17:41
°Ë»öÇϱâ
ÀαâmouGEÇÐȸ

[º´¿ø/ÀÇ·á > ÀÇ·á]

GC³ì½ÊÀÚÀÇ·áÀç´Ü, ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ±¹Á¦Çмú´ëȸ

ÀÌÀ缺 ±âÀÚ / scmdnews@hanmail.net
½ÂÀÎ 24-09-30 12:10 | ÃÖÁ¾¼öÁ¤ 24-09-30 12:10  
 

GC³ì½ÊÀÚÀÇ·áÀç´Ü(´ëÇ¥¿øÀå ÀÌ»ó°ï)Àº Áö³­ 9¿ù 25ÀÏ(¼ö)ºÎÅÍ 27ÀÏ(±Ý)±îÁö ¼­¿ï °­³²±¸ ÄÚ¿¢½º¿¡¼­ °³ÃÖµÈ ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ±¹Á¦Çмú´ëȸ(ÀÌÇÏ LMCE 2024)¸¦ ¼ºÈ²¸®¿¡ ¸¶ÃÆ´Ù°í 30ÀÏ ¹àÇû´Ù.

 

À̹ø LMCE 2024´Â Àü ¼¼°è 30°³±¹¿¡¼­ 2,500¸í ÀÌ»óÀÇ ±¹³»¿Ü Àü¹®°¡µéÀÌ Âü¼®ÇßÀ¸¸ç, ¡®Digital Transformation of Laboratory Medicine: Empowering Diagnostics¡¯¸¦ ÁÖÁ¦·Î Áø´Ü°Ë»ç ºÐ¾ßÀÇ ÃֽŠÁ¤º¸¿Í ¿¬±¸ µ¿Çâ¿¡ ´ëÇÑ È°¹ßÇÑ ±³·ù°¡ ÀÌ·ïÁ³´Ù. 

 

GC³ì½ÊÀÚÀÇ·áÀç´ÜÀº GC³ì½ÊÀÚ »êÇÏ °è¿­»çÀÎ GCÁö³ð, GC¼¿°ú ÇÔ²² °ñµå ½ºÆù¼­·Î °øµ¿ Âü°¡ÇØ ÅëÇÕ Àü½Ã ºÎ½º¸¦ ¿î¿µÇß´Ù. Àç´ÜÀÇ °Ëü°Ë»ç ¼öŹ ¼­ºñ½º, GCÁö³ðÀÇ ÀÓ»óÀ¯Àüü ºÐ¼® ¼­ºñ½º, GC¼¿ÀÇ ¼¼Æ÷Ä¡·áÁ¦ ¹× ¹ÙÀÌ¿À ¹°·ù ¼­ºñ½º¸¦ È«º¸Çϸç Áø´Ü°Ë»ç ÅëÇÕ ¼Ö·ç¼ÇÀ» ¼±º¸¿´´Ù. ƯÈ÷ Àç´ÜÀº Ãֱ٠ȣ³² ºÐ¿ø È®ÀåÀÌÀü°ú ¿µ³² ºÐ¿ø °³¿ø ¼Ò½ÄÀ» ÀüÇϸç, Áö¿ª»çȸ ±â¹ÝÀÇ °Ëü °Ë»ç ¼­ºñ½º¸¦ ´õ¿í °­È­ÇØ ³ª°¡°í ÀÖÀ½À» °­Á¶Çß´Ù.

 

Àç´Ü ¼Ò¼Ó Àü¹®ÀǵéÀº ÁÂÀå ¹× ¿¬ÀÚ·Î Âü¼®ÇØ ´Ù¾çÇÑ ¿¬±¸ ¼º°ú¸¦ °øÀ¯Çß´Ù. 

 

¸ÕÀú, 25ÀÏ(¼ö) ÁøÇàµÈ Pre-Congress¿¡¼­ Á¶¼ºÀº ³»ºÐºñ¹°ÁúºÐ¼®¼¾ÅÍÀåÀÌ ¡®Application of Mass Spectrometry in Standardization of Laboratory Medicine¡¯¿¡ ´ëÇÑ ¹ßÇ¥·Î ù ¹®À» ¿­¾úÀ¸¸ç, À̾î 26ÀÏ(¸ñ) ±¸¿¬¹ßÇ¥ ¼¼¼Ç¿¡¼­ ¡®Implementation of Revvity Janus G3 Automated Workstations for Pretreatment Steps of Liquid Chromatography with Tandem Mass Spectrometry Analyzing Metanephrine and Normetanephrine¡¯À» ÁÖÁ¦·Î ¹ßÇ¥Çß´Ù.

 

26ÀÏ(¸ñ) ÁøÇàµÈ ¿¡µàÄÉÀÌ¼Ç ¿öÅ©¼ó¿¡¼­´Â °í¿î¿µ °¨¿°º´¿¬±¸¼¾ÅÍÀå°ú Àºº´¿í ³ë¿øÀ»Áö´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ±³¼ö°¡ ¡®Differential Diagnosis and Surveillance of Mycoplasma Pneumoniae and Respiratory Viral Infection¡¯À» ÁÖÁ¦·Î ¸¶ÀÌÄÚÇö󽺸¶ Æó·Å°ú È£Èí±â ¹ÙÀÌ·¯½º °¨¿°º´ÀÇ °¨º° Áø´Ü ¹× °¨½Ã¿Í GC³ì½ÊÀÚÀÇ·áÀç´ÜÀÌ ºòµ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ È£Èí±â°¨¿°ÁõÀÇ À¯ÇàÀ» °¨ÁöÇÏ°í Ãß¼¼¸¦ ¸ð´ÏÅ͸µÇϱâ À§ÇØ °³¹ßÇÑ È£Èí±â°¨¿°Áõ´ë½Ãº¸µå¿¡ ´ëÇØ ¼Ò°³Çß´Ù.

 

¶ÇÇÑ, 26ÀÏ(¸ñ) ÀÌÀºÈñ ÀÌ»çÀåÀº ¡®Artificial Intelligence and Innovation in Laboratory Medicine¡¯ ½ÉÆ÷Áö¾öÀÇ ÁÂÀåÀ» ¸Ã¾ÒÀ¸¸ç, ÃÖ¸®È­ Àü¹®ÀÇ´Â ¡®Practice Characteristics and Relative Value of Clinical Pathologists¡¯ ½ÉÆ÷Áö¾ö¿¡¼­ ¡®Practice Characteristics and Relative Value of Clinical Pathologists¡¯ Work in Specialized Tests¡¯¿¡ ´ëÇØ ¹ßÇ¥Çß´Ù. ¸¶Áö¸· ³¯ÀÎ 27ÀÏ(±Ý)¿¡´Â ÀÌ»ó°ï ´ëÇ¥¿øÀåÀÌ ¡®The Essentials of Laboratory Management¡¯ ½ÉÆ÷Áö¾ö¿¡¼­ ¡®Fundamentals of Financial Management¡¯¸¦ ÁÖÁ¦·Î ¹ßÇ¥Çß´Ù. 

 

Àç´Ü ¼Ò¼Ó Àü¹®ÀÇ 5¸íÀÌ Æ÷½ºÅÍ ¹ßÇ¥µµ ÁøÇàÇß´Ù. ¹ßÇ¥ ³»¿ëÀº ¡â¹Ú¹ÌÁ¤ Àü¹®ÀÇ ¡®Evaluation of Analytical Performance of the BS-620M Chemical Analyzer for HbA1c Assay¡¯ ¡â¼Û¼º¿í Àü¹®ÀÇ ¡®Changes in Prevalence of Respiratory Viruses Before, During and after the COVID-19 Pandemic¡¯ ¡âÀ̾ƶ÷ Àü¹®ÀÇ ¡®Serum or Plasma Aldosterone to Plasma Renin Activity Ratio test: Experience of a Clinical Laboratory in Korea¡¯ ¡âÀÌÁØÇü Àü¹®ÀÇ ¡®Development of Artificial Intelligence for Interpretation of Immunofixation Electrophoresis using Deep Learning¡¯ ¡âÇã±ÔÈ­ Àü¹®ÀÇ ¡®Evaluation of the ASTA MicroIDSys Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry system for identification of nontuberculous mycobacteria¡¯´Ù.

 

ÀÌ¿Í ´õºÒ¾î, ³»ºÐºñ¹°ÁúºÐ¼®¼¾ÅÍÀÇ ÀÌÁØÇü Àü¹®ÀÇ¿Í À̾ƶ÷ Àü¹®ÀÇ°¡ ÀÓ»óÈ­ÇÐ ºÎ¹®¿¡¼­ ¿ì¼öÆ÷½ºÅÍ»óÀ» ¼ö»óÇß´Ù. 

 

ÀÌ»ó°ï GC³ì½ÊÀÚÀÇ·áÀç´Ü ´ëÇ¥¿øÀåÀº ¡°±¹³»¸¦ ³Ñ¾î ¾Æ½Ã¾Æ¸¦ ´ëÇ¥ÇÏ´Â Áø´Ü°Ë»ç ºÐ¾ß ±¹Á¦ Çмú´ëȸÀÎ LMCE 2024¿¡¼­ Àç´ÜÀÇ ¶Ù¾î³­ ¿¬±¸ ¼º°ú¿Í ÇмúÀû ±â¿©¸¦ ÀÔÁõÇÏ°í ºê·£µå °¡Ä¡¸¦ °­È­ÇÒ ±âȸ¸¦ ¸¶·ÃÇß´Ù¡±¸ç ¡°¾ÕÀ¸·Îµµ È°¹ßÇÑ ¿¬±¸¿Í Çмú È°µ¿À» À̾¸ç Áø´Ü°Ë»çÀÇÇÐÀÇ ¹ßÀü°ú ¼¼°è º¸°Ç Çâ»ó¿¡ ±â¿©ÇÒ °Í¡±À̶ó°í ¸»Çß´Ù. 


 
 
Copyright¨Ï»çÀ̾𽺿¥µð´º½º ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö
   
 
 
 
 
³×ƼÁð ÀÇ°ß(0)
³»¿ë ¾ÆÀ̵ð ÀÛ¼ºÀÏ
 
ÀÇ°ßÀÛ¼ºÇϱâ
 
 
À̸§ ºñ¹Ð¹øÈ£
 
ÀÌ´ë¸ñµ¿º´¿ø, °Ç°­Á¤º¸ °í¼Óµµ·Î »ç¾÷ °³Åë½Ä °³ÃÖ
¿ëÀμ¼ºê¶õ½º ¹ÚÁø¿µ ¼ÒÀå, ÄÚ¸®¾Æºòµ¥ÀÌÅÍAI¾î¿öµå °ú±âºÎÀå°üǥâ
ÀÇ·á ±â»ç¸ñ·Ï º¸±â
 
Àαⴺ½º
GC³ì½ÊÀÚÀÇ·áÀç´Ü, ´ëÇÑÁø´Ü°Ë..
GC³ì½ÊÀÚÀÇ·áÀç´Ü 'Áø´Ü°Ë»çÀÇ..
'¹ßº´À² 10´ë¾Ï' ½Å¼¼Æ÷¾Ï ..
Àá½ÇÂ÷º´¿ø ³­ÀÓ¼¾ÅÍ, 26ÀÏ ±¹..
¸ð´õ³ªÄÚ¸®¾Æ, ÀÇ·áÁø ´ë»ó ÄÚ..
 
¸¹ÀÌ º» Æ÷Åä´º½º
ÀÇÁ¤ºÎÀ»Áö´ëº´¿ø ¡®Ã£¾Æ°¡´Â ..
ÇÏÀ̷δÐ, ¸¶½ºÅÏ-EDCÞä µî°ú ..
±æ¸®¾îµå, ¿¬¼¼¾Ïº´¿ø°ú Ç×¾Ï..
"¿ì·ç»ç' ´ë¿õ ÀÓÁ÷¿ø Âü¿© '..
 
ÃֽŠÀαⴺ½º
GC³ì½ÊÀÚÀÇ·áÀç´Ü, ´ëÇÑÁø´Ü°Ë..
GC³ì½ÊÀÚÀÇ·áÀç´Ü 'Áø´Ü°Ë»çÀÇ..
¼­¿ï´ëº´¿ø, À¯¹æ¾Ï Ä¡·á ÈÄ ..
ºÐ´çÁ¦»ýº´¿ø ºñ´¢ÀÇÇаú, ·Î..
IVI ±Û·Î¹ú Àü¹®°¡ ÀÚ¹®À§¿øȸ..